Clinical Trial Update: The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing triple inhaled therapy (fluticasone furoate/vilanterol/umeclidinium) to dual therapy (vilanterol/umeclidinium) in COPD to assess impro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)
• Umeclidinium (umeclidinium)
• Vilanterol (vilanterol)

Snippet

Sponsor: Mahidol University | Conditions: COPD | Phase 3 | Status: RECRUITING